Clinical reference
Antiviral · Antiviral agent, nucleoside analogue reverse transcriptase inhibitor · Infectious Diseases, Obstetrics, Pediatrics
Zidovudine is an NRTI for HIV. Formulations: capsules 100 mg; tablets 300 mg; oral syrup 50 mg/5 mL (240 mL); injection 10 mg/mL (20 mL), preservative-free (vial stoppers may contain latex). Combivir: 300 mg zidovudine + 150 mg lamivudine. Trizivir: 300 mg zidovudine + 300 mg abacavir + 150 mg lamivudine. HIV treatment: see https://clinicalinfo.hiv.gov/en…